Journal
DIABETOLOGIA
Volume 56, Issue 11, Pages 2498-2506Publisher
SPRINGER
DOI: 10.1007/s00125-013-3029-3
Keywords
Adipogenesis; Adipose tissue; BSCL2; Lipin; Lipodystrophy; Seipin
Categories
Funding
- Medical Research Council (MRC) [GO800203, G09000554]
- Wellcome Trust [078986/Z/06/Z, 089125/Z/09/Z]
- Agency for Science, Technology and Research, Singapore (A*STAR)
- MRC Centre for Obesity and Related Metabolic Disorders (MRC-CORD) [GO600717]
- National Institute for Health Research Comprehensive Biomedical Research Centre [CG50826]
- Islamic Development Bank
- Medical Research Council [G0800203, MC_UU_12012/5/B, G0600717B, G0600717] Funding Source: researchfish
- MRC [G0600717, G0800203] Funding Source: UKRI
- Wellcome Trust [089125/Z/09/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
In humans, disruption of the gene BSCL2, encoding the protein seipin, causes congenital generalised lipodystrophy (CGL) with severe insulin resistance and dyslipidaemia. While the causative gene has been known for over a decade, the molecular functions of seipin are only now being uncovered. Most pathogenic mutations in BSCL2 represent substantial disruptions including significant deletions and frameshifts. However, several more subtle mutations have been reported that cause premature stop codons or single amino acid substitutions. Here we have examined these mutant forms of seipin to gain insight into how they may cause CGL. We generated constructs expressing mutant seipin proteins and determined their expression and localisation. We also assessed their capacity to recruit the key adipogenic phosphatidic acid phosphatase lipin 1, a recently identified molecular role of seipin in developing adipocytes. Finally, we used atomic force microscopy to define the oligomeric structure of seipin and to determine whether this is affected by the mutations. We show that the R275X mutant of seipin is not expressed in pre-adipocytes. While the other premature stop mutant forms fail to bind lipin 1 appropriately, the point mutants T78A, L91P and A212P all retain this capacity. We demonstrate that wild-type human seipin forms oligomers of 12 subunits in a circular configuration but that the L91P and A212P mutants of seipin do not. Our study represents the most comprehensive analysis so far of mutants of seipin causing lipodystrophy and reveals several different molecular mechanisms by which these mutations may cause disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available